Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
Open | $20.970 |
Close | $20.570 |
Volume / Avg. | 567.688K / 672.105K |
Day Range | 20.440 - 21.260 |
52 Wk Range | 20.948 - 79.650 |
Market Cap | $1.105B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 18.98% |
Days to Cover | 10.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Other companies in Prothena Corp’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Cantor Fitzgerald on Wednesday, April 10, 2024. The analyst firm set a price target for 0.00 expecting PRTA to fall to within 12 months (a possible -100.00% downside). 27 analyst firms have reported ratings in the last year.
The stock price for Prothena Corp (NASDAQ: PRTA) is $20.57 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Prothena Corp.
Prothena Corp’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Prothena Corp.
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.